Anzeige
Mehr »
Login
Donnerstag, 25.04.2024 Börsentäglich über 12.000 News von 687 internationalen Medien
Solarboom 2024: Fünf Gründe, die für diese Aktie sprechen!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
51 Leser
Artikel bewerten:
(0)

Germany Bioinformatics Market Forecast and Opportunities, 2020 - Major Players Include Affymetrix, Biovia, Biomax Informatics and Agilent Technologies

DUBLIN, July 07, 2015 /PRNewswire/ --

Research and Markets (http://www.researchandmarkets.com/research/356mmr/germany) has announced the addition of the "Germany Bioinformatics Market Forecast and Opportunities, 2020" report to their offering.

600769

The bioinformatics market in Germany is projected to surge at a CAGR over 29% during 2015-20

Growing trend of information fusion and increase in number of academia partnerships to provide more insights for research & development activities is propelling demand for bioinformatics solutions for storage and processing of data in the country. Increasing lifespan of population in Germany is expected to drive new drug discovery and development, thus propelling demand for bioinformatics based technologies. Presently, Genomics and Proteomics, which are currently the major application segments in the country's bioinformatics market, are expected to maintain their dominance through 2020.

Major players operating in Germany's bioinformatics market include Affymetrix, Biovia, Biomax Informatics and Agilent Technologies.

Germany bioinformatics market is one of the fastest growing bioinformatics market in Europe. Rising concerns over data management and growing role of IT in drug discovery is driving the country's bioinformatics market. Mounting demand for innovative medical solutions for treatment of diseases, decoding genetic constitution of an organism, studying climatic changes, rising use of microbial genome information for waste clean-up, antibiotic resistance, evolutionary studies, and increasing funding by government and private organizations are the major factors driving bioinformatics market in Germany. In addition to adoption of new technologies, increasing need for reducing failures related to drug discovery and maintaining bioinformatics database of genes, protein, etc. is boosting demand for bioinformatics solutions. Growing trend towards genome and protein sequencing, and increasing demand for personalized medicines, coupled with advancements in cloud technologies and nanopore sequencing methods is forecast to drive the market through 2020.

Germany Bioinformatics Market Forecast & Opportunities, 2020 discusses the following aspects of bioinformatics market in Germany:

  • Germany Bioinformatics Market Size, Share & Forecast
  • Segmental Analysis - By Bioinformatics Products & Services (Bioinformatics Services, Bioinformatics platform, Bioinformatics Knowledge Management Tools), By Applications (Genomics, Proteomics, Transcriptomics, etc.)
  • Policy and Regulatory Landscape
  • Changing Market Trends & Emerging Opportunities
  • Competitive Landscape & Strategic Recommendations

Trends & Developments

  • Advancing Research and Development (R&D) Activities
  • Market Consolidation
  • Academia Partnerships
  • Growing role of IT in Drug Discovery
  • Increase in Number of Government Initiatives for Genome Sequencing

Key Topics Covered:

1. Research Methodology

2. Analyst View

3. Bioinformatics Overview

4. Global Bioinformatics Market Outlook

5. Germany Bioinformatics Market Landscape

6. Germany Bioinformatics Market Outlook

7. Market Dynamics

8. Trends & Developments

9. Germany Bioinformatics Market- SWOT Analysis

10. Policy & Regulatory Landscape

11. Germany Economic Profile

12. Competitive Landscape

13. Strategic Recommendations

Companies Mentioned

- Affymetrix GmbH
- Agilent Technologies
- Biomax Informatics AG
- Biovia (formerly known as Accelrys)
- ID Business Solutions
- Illumina GmbH
- Life Technologies GmbH
- PerkinElmer Holding GmbH
- QIAGEN GmbH
- Roche Diagnostics GmbH

For more information visit http://www.researchandmarkets.com/research/356mmr/germany

Media Contact: Laura Wood , +353-1-481-1716, press@researchandmarkets.net

Großer Insider-Report 2024 von Dr. Dennis Riedl
Wenn Insider handeln, sollten Sie aufmerksam werden. In diesem kostenlosen Report erfahren Sie, welche Aktien Sie im Moment im Blick behalten und von welchen Sie lieber die Finger lassen sollten.
Hier klicken
© 2015 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.